mitotane and pasireotide

mitotane has been researched along with pasireotide in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's6 (85.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leal-Cerro, A; León Justel, A; Mangas, MA; Soto Moreno, A; Webb, S1
Biller, BM; Tritos, NA1
Barahona Constanzo, MJ; del Pozo Picó, C1
Feelders, RA; Hofland, LJ1
Gadelha, MR; Vieira Neto, L1
Aghi, MK; Lau, D; Rutledge, C1
Biller, BMK; Tritos, NA1

Reviews

7 review(s) available for mitotane and pasireotide

ArticleYear
[The medical management of Cushing's syndrome].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2009, Volume: 56, Issue:4

    Topics: Adrenal Cortex; Adrenalectomy; Adrenocorticotropic Hormone; Aminoglutethimide; Combined Modality Therapy; Cushing Syndrome; Dopamine Agonists; Glucocorticoids; Humans; Hydrocortisone; Hypophysectomy; Imidazoles; Mitotane; Pituitary Gland, Anterior; Rosiglitazone; Somatostatin; Thiazolidinediones

2009
Advances in medical therapies for Cushing's syndrome.
    Discovery medicine, 2012, Volume: 13, Issue:69

    Topics: Animals; Bexarotene; Cushing Syndrome; Etomidate; Humans; Ketoconazole; Lapatinib; Metyrapone; Mifepristone; Mitotane; Quinazolines; Somatostatin; Tetrahydronaphthalenes

2012
New prospects for drug treatment in Cushing disease.
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2012, Volume: 59, Issue:10

    Topics: Adenoma; Adrenocorticotropic Hormone; Animals; Cabergoline; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Drug Evaluation, Preclinical; Ergolines; Etomidate; Humans; Hydrocortisone; Imidazoles; Ketoconazole; Metyrapone; Mice; Mifepristone; Mitotane; Multicenter Studies as Topic; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; PPAR gamma; Pyridines; Rats; Somatostatin; Therapies, Investigational; Tretinoin

2012
Medical treatment of Cushing's disease.
    The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:2

    Topics: Antineoplastic Agents, Hormonal; Dopamine Agonists; Humans; Mitotane; Octreotide; Pituitary ACTH Hypersecretion; Receptors, Glucocorticoid; Somatostatin

2013
Efficacy of medical treatment in Cushing's disease: a systematic review.
    Clinical endocrinology, 2014, Volume: 80, Issue:1

    Topics: Cabergoline; Ergolines; Female; Humans; Ketoconazole; Male; Metyrapone; Mitotane; Pituitary ACTH Hypersecretion; Somatostatin

2014
Cushing's disease: current medical therapies and molecular insights guiding future therapies.
    Neurosurgical focus, 2015, Volume: 38, Issue:2

    Topics: Clinical Trials as Topic; Drug Delivery Systems; Female; Forecasting; Humans; Male; Mitotane; Pituitary ACTH Hypersecretion; Receptors, Retinoic Acid; Retrospective Studies; Somatostatin

2015
Medical Management of Cushing Disease.
    Neurosurgery clinics of North America, 2019, Volume: 30, Issue:4

    Topics: Cabergoline; Etomidate; Humans; Ketoconazole; Metyrapone; Mitotane; Pituitary ACTH Hypersecretion; Somatostatin; Temozolomide; Treatment Outcome

2019